[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344928-105":59,"doc-detail-344928-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","senp3-drives-colorectal-cancer-progression-by-enhancing-gdf15-expression","SENP3 drives colorectal cancer progression by enhancing GDF15 expression","","SUMO-specific peptidase 3 (SENP3) functions as a de-SUMOylating enzyme, enabling reversible protein SUMOylation. Although SENP3 has been reported to either promote or inhibit tumor phenotypes in multiple cancers, its role in colorectal cancer (CRC) is not defined. Analyses of CRC tissues and functional assays in vitro and in vivo evaluated SENP3-driven effects, supported by proteomic profiling to determine downstream mechanisms. Results show elevated SENP3 linked to poor survival, promoting growth through stabilization of GDF15.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/senp3-drives-colorectal-cancer-progression-by-enhancing-gdf15-expression/344928/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/senp3-drives-colorectal-cancer-progression-by-enhancing-gdf15-expression/344928.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What biological role does SENP3 play in SUMOylation?","Question",{"text":112,"@type":113},"SENP3 is a de-SUMOylating enzyme that renders the SUMOylation process reversible, regulating protein SUMO modifications.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does SENP3 affect colorectal cancer progression according to the results?",{"text":117,"@type":113},"SENP3 is elevated in cancerous tissues and correlates with reduced patient survival; it promotes cell growth in vitro and boosts tumorigenicity in vivo.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism links SENP3 to CRC progression?",{"text":121,"@type":113},"Proteomic analysis indicates GDF15 is a downstream effector of SENP3, and MG132 treatment supports that SENP3 enhances GDF15 stability; cellular and mouse studies show SENP3 regulates CRC progression via GDF15.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},344928,1790216431,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","International Journal of Colorectal Disease (2026) 41:80  \n[https://doi.org/10.1007/s00384-026-05120-y](https://doi.org/10.1007/s00384-026-05120-y)  \nSENP3 drives colorectal cancer progression by enhancing GDF15 expression  \nYang Yu1 · Wenfang Bao1 · Jingde Chen1 · Yandong Li1 · Yong Gao1  \nReceived: 21 October 2025 / Revised: 10 February 2026 / Accepted: 2 March 2026 © The Author(s) 2026  \nAbstract  \nBackground SUMO-specific peptidase 3 (SENP3), as a de-SUMOylating enzyme, renders the process of protein SUMOylation reversible. It has been demonstrated to play either promoting or inhibitory roles in several cancers. However, research on its function in colorectal cancer (CRC) remains absent.  \nMethods Tissue samples from CRC patients were analyzed to measure the expression level of SENP3 . Proliferation and viability assays were performed to assess the role of SENP3 in cell growth. The mouse model was established to evaluate the effect of SENP3 on the growth of xenografts derived from CRC cells. To investigate the mechanisms of SENP3 in CRC, proteomic analysis was conducted.  \nResults We identified an elevated expression of SENP3 in cancerous tissues, which correlated with a reduced survival rate in CRC patients. SENP3 promoted cell growth in vitro and boosted tumorigenicity in vivo as a potential oncogenic factor. In terms of mechanism, proteomic analysis revealed that growth differentiation factor 15 (GDF15) is a downstream effector of SENP3 . Treatment with MG132 confirmed that SENP3 enhances the stability of GDF15 . Through a series of cellular functional experiments and mouse model establishment, we demonstrated that SENP3 regulates CRC progression by acting on GDF15 .  \nConclusion Based on our findings, we define a key role for SENP3 in colorectal cancer progression and suggest it as a viable target for therapeutic intervention.  \nKeywords SENP3 · GDF15 · Colorectal cancer · Tumor growth  \nYang Yu, Wenfang Bao, and Jingde Chen contributed equally to this work.  \n* Yandong Li [yandongli2009@gmail.com](yandongli2009@gmail.com)  \n* Yong Gao [drgaoyong@tongji.edu.cn](drgaoyong@tongji.edu.cn)  \nYang Yu  \n[yyyuyang0228@163.com](yyyuyang0228@163.com)  \nWenfang Bao  \n[bwf1025@163.com](bwf1025@163.com)  \nJingde Chen  \n[1600092@tongji.edu.cn](1600092@tongji.edu.cn)  \n1 Department of Oncology, School of Medicine, Shanghai East Hospital, Tongji University, Shanghai 200120, China  \nIntroduction  \nIn today’s world, it is widely recognized that cancer remains a considerable challenge to human health. Global cancer statistics indicate that colorectal cancer holds the position of the third most frequent among all types of cancer, and its mortality rate ranks as the second highest [1]. Moreover, this trend is anticipated to worsen with ongoing socioeconomic development [2] . Therefore, enhancing the treatment efficacy of colorectal cancer and exploring relevant healthcare services can significantly alleviate the substantial social burden imposed by colorectal cancer [3] .  \nWith the in-depth understanding of the human genome through scientific study, the notable impact of proteomicson the onset and progression of cancer has been unveiled [4]. In recent years, post-translational modifications (PTMs) have made significant breakthroughs in the field of cancer research [5] . Scientists have identified more than 650 types of protein modifications to date; these include ubiquitination,  \nphosphorylation, glycosylation, methylation, and SUMOylation, and the expanding repertoire reflects ongoing discovery in the field. PTMs alter the function and interactions of target proteins by modifying specific residues, rather than by altering the DNA sequence [6–9] . Among the diverse array of post-translational modifications, SUMOylation has emerged as a particularly significant process, owing to its crucial role in dynamically modulating protein stability, subcellular localization, and functional activity—mechanisms often disrupted in cancer pathogenesis","cbCaioyA3D5Kck3y","https://ap.wps.com/l/cbCaioyA3D5Kck3y","pdf",1883017,12,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Cancer burden and PTMs\n## Role of SENP3 in other cancers\n## Rationale for studying SENP3 in CRC\n# Method and materials\n## Plasmids, siRNAs, and shRNA","[{\"question\":\"What biological role does SENP3 play in SUMOylation?\",\"answer\":\"SENP3 is a de-SUMOylating enzyme that renders the SUMOylation process reversible, regulating protein SUMO modifications.\"},{\"question\":\"How does SENP3 affect colorectal cancer progression according to the results?\",\"answer\":\"SENP3 is elevated in cancerous tissues and correlates with reduced patient survival; it promotes cell growth in vitro and boosts tumorigenicity in vivo.\"},{\"question\":\"What mechanism links SENP3 to CRC progression?\",\"answer\":\"Proteomic analysis indicates GDF15 is a downstream effector of SENP3, and MG132 treatment supports that SENP3 enhances GDF15 stability; cellular and mouse studies show SENP3 regulates CRC progression via GDF15.\"}]","SENP3 drives colorectal cancer progression by enhancing GDF15 expression | PDF",1790055808,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51e9330dcd866d440a67cab45741e267.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33b482ffbaaaf5403decfdb5188a7ac2.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8811f9510f0a0c8282cfe94e8a0a4528.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50f96b4124ea449829f4ab9c8eec588b.webp",980,1301]